Olema Pharmaceuticals, Inc., also known as Olema Oncology, is a clinical-stage biopharmaceutical company based in San Francisco, CA. They are dedicated to the discovery, development, and commercialization of targeted therapies for women's cancers. With a strong focus on endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance, Olema Oncology aims to transform the standard of care for women living with cancer by developing more convenient and effective therapies.
Driven by a powerful mission, Olema Oncology challenges themselves to improve the lives of others by designing therapies that offer the potential to enhance outcomes for women with cancer. They leverage their deep understanding of the disease and its mechanisms to develop innovative treatments. With a goal to advance into clinical development by the end of 2024, Olema Oncology is committed to making a significant impact in the field of oncology.
Generated from the website